Voting Result of Postal Ballot conducted by remote e-voting along with the Scrutinizer Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics conducted a postal ballot via remote e-voting to seek shareholder approval for the re-appointment and remuneration of Dr. Pankaj Shah (DIN: 02836324) as Managing Director & CEO for a fresh term of three consecutive years. The e-voting window ran from June 11, 2025 to July 10, 2025, and the scrutinizer (Prajakta V. Padhye of Nilesh A. Pradhan & Co., LLP) confirmed the special resolution was passed with the requisite majority. All 13 members who voted (holding 22,59,583 shares) cast their votes in favour, representing 100% of valid votes, with zero votes against and zero invalid/abstained votes. Out of 1,790 eligible shareholders on the record date, only 13 participated in the voting.
Dr. Pankaj Shah will continue as MD & CEO for another three-year term, providing leadership continuity for the company. Shareholders have fully endorsed his re-appointment and remuneration, though the very low voting participation (13 out of 1,790 shareholders) suggests passive retail/investor engagement.